Investigation Overview
San Diego, Feb. 6, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Par Pharmaceutical Companies, Inc. (NYSE:PRX) shares over possible breaches of fiduciary duties by certain directors and officers at Par Pharmaceutical Companies was announced. The investigation by a law firm focuses on possible NYSE:PRX shareholder claims based on potential breaches of fi...
You must register (for free) or login to view the entire investigation.